HVIVO PLC
HVIVO PLC ORD 0.1P HVO.L · LSE
Live GBP 0.07 ▲ 0.00 (1.54%)
Mkt Cap £45.43M
Volume 750,249
52W 4.31 – 11.00
🔔 Sign in to receive sentiment alerts for HVIVO PLC.
Market Sentiment
Sentiment Grade
A
↓ Declining (-21.0 pts vs 7-day avg)
HVIVO PLC
Positive Sentiment
7.2/10
Sentiment Index
Very NegativeNeutralVery Positive
82%
Avg Confidence
69 / 0
Positive / Negative articles
📰 Based on 100 articles from 29 sources Proactive Investors ×23 Proactive financial news ×12 London South East ×10 Yahoo Finance UK ×9 TradingView ×7
📊 Moderate volatility — MEVI 22.7/100
🕐 Updated 3 hours ago
📋 Today's context
Daily AI-generated context for this company — recent events, market backdrop, and supporting developments. Available to Pro Investor members.
Sentiment Distribution
Sentiment Trend
Latest RNS & Market News
- HVIVO PLC – Hvivo Acquires Crs BerlinRNS Number : 3273S hVIVO PLC 27 August 2026 hVIVO plc (“hVIVO”, the “Company” or the “Group”) hVIVO acquires CRS Berlin, expanding expertise into dermatology and women’s health markets London, UK – 27 August 2026, hVIVO plc (AIM: HVO), a purpose-built, full-service international clinical development partner and the world leader in…
- HVIVO PLC – H1 2026 Trading UpdateRNS Number : 4847N hVIVO PLC 23 July 2026 hVIVO plc (“hVIVO”, the “Company” or the “Group”) H1 2026 Trading Update Strong commercial momentum drives more than doubling of orderbook London, UK – 23 July 2026, hVIVO plc (AIM: HVO), a purpose-built, full-service international clinical development partner and the world leader…
- HVIVO PLC – Notice Of ResultsRNS Number : 3552Z hVIVO PLC 07 April 2026 hVIVO plc (“hVIVO”, the “Company” or the “Group”) Notice of Results London, UK – 7 April 2026, hVIVO plc (AIM: HVO), a full-service early phase Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, announces that it will release its…